Against the backdrop of strengthening rebound, it was bought up to 1878 yen on the 4th. Although it has shown some adjustment afterwards, as it has dropped to the 25-day moving average line which is recognized as a support line, it seems to be a timing to aim for a rebound. Recently, there has also been an announcement of success in the trial of administering a high dose of iPS cell-derived myocardial cells, so there is likely a strong buying interest in waiting for dips.